
POP Biotechnologies
POP Biotechnologies, a Buffalo-based life sciences company, pioneers in next-gen nanomedicine solutions.

POP Biotechnologies, a Buffalo-based life sciences company, pioneers in next-gen nanomedicine solutions.
POP Biotechnologies, founded in Buffalo, NY, is a pioneering life sciences company focused on developing next-generation nanomedicine solutions. The company's core mission is to enhance individual health through innovative nanotechnology applications. Their product offerings include advanced drug delivery systems and therapeutic platforms aimed at addressing critical health issues such as obesity and heart disease. POP Biotechnologies targets the healthcare market, seeking to provide cutting-edge treatments that improve patient outcomes.
Notable figures associated with POP Biotechnologies include leading scientists and industry experts in the field of nanomedicine. The company has attracted significant interest from investors who are keen on supporting breakthrough technologies in healthcare. Key achievements include the development of proprietary nanotechnology platforms that have shown promising results in preclinical trials. Overall, POP Biotechnologies has made a substantial impact by pushing the boundaries of traditional medicine and offering potential new solutions for complex health challenges.
Companies similar to POP Biotechnologies include Therapyx, BioNanovations, Nano RED and Optimeos Life Sciences.
POP Biotechnologies was founded in 2015.
POP Biotechnologies' headquarters is located in Buffalo, NY, US.
POP Biotechnologies' most recent funding round was for $4M (USD) in July 2021.
As of Jul 29, 2021, POP Biotechnologies has disclosed funding of $4.7M (USD). Undisclosed round amounts are excluded.
POP Biotechnologies has 5 employees as of Feb 4, 2024.
Optimeos Life Sciences
optimeos.com